Learners will enhance their knowledge on candidate guideline recommendation/s from the release of the 2022 AHA/American College of Cardiology/Heart Failure Society of America guideline for managing Heart Failure. This activity will also cover the latest clinical findings on the effects of new SGLT2 inhibitors such as ertugliflozin, licogliflozin (LIK066), henagliflozin, bexagliflozin, and sotagliflozin on the Stage A Heart Failure and Metabolic Syndrome Outcomes in individuals without DM, HF, and/or CKD.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Top 6 courses
-
2026 Digital Health Webinar1.5 Credits
-
-
-
-
-
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Hospital Medicine
- Infectious Disease
- Medical Toxicology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pediatric Infectious Diseases
- Rheumatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.
- Journal-based
- Credit · Up to 1 credit
- Fee · varies
-
ReleasedDec 1, 2023
-
Last day to claim creditDec 2, 2026 7 weeks left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Arm-in-Arm With Heart Failure Experts: A Master Class in Optimizing Heart Failure Treatment With SGLT2 Inhibitors
-
Cardiometabolic Health Congress (CMHC) +1 Transforming Cardiorenal Care: Timely Diagnosis and Guideline-driven Management of Heart Failure and Chronic Kidney Disease
-
Haymarket Medical Education Advancing Heart Failure and CKD Care Through Aldosterone Modulation: Emerging Strategies For Practice Provider
-
American College of Clinical Pharmacology 2023 ACCP Journal of Clinical Pharmacology Journal CE | November 2023
-
American College of Clinical Pharmacology 2024 ACCP Journal of Clinical Pharmacology Journal CE | April 2024
-
American College of Clinical Pharmacology 2024 ACCP Journal of Clinical Pharmacology Journal CE | March 2024
